Menstrual Factors, Reproductive History, Hormone Use, and Urothelial Carcinoma Risk: A Prospective Study in the EPIC Cohort.
Leila Lujan-BarrosoEdoardo BotteriSaverio CainiBörje LjungbergNina RoswallAnne TjønnelandBas Bueno-de-MesquitaInger Torhild GramRosario TuminoLambertus A L M KiemeneyFredrik LiedbergTanja StocksMarc J GunterNeil MurphyIris CervenkaAgnès FournierMarina KvaskoffChristel HäggströmKim OvervadEiliv LundMarit WaasethRenée Turzanski FortnerTilman KühnVirginia MenéndezMaria-José SánchezCarmen SantiusteAurora Perez-CornagoRaul Zamora RosAmanda J CrossAntonia TrichopoulouAnna KarakatsaniEleni PeppaDomenico PalliVittorio KroghVeronica SciannameoAmalia MattielloSalvatore PanicoCarla H van GilsN Charlotte Onland-MoretAurelio Barricarte-GurreaPilar AmianoKay-Tee KhawHeiner BoeingElisabete WeiderpassEric Jeffrey DuellPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)
More detailed studies on parity are needed to understand the possible effects of perinatal hormone changes in urothelial cells.